Aflac Incorporated (AFLAC) - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for Aflac Incorporated and subsidiaries for the period ended September 30, 2006. Aflac primarily sells supplemental health and life insurance in the United States and Japan. The company operates through two main reportable segments: Aflac Japan and Aflac U.S.. As of October 31, 2006, there were 494,503,936 shares of common stock outstanding.
Key Financial Metrics (Nine Months Ended Sept 30, 2006)
| Metric | 2006 (9 Months) | 2005 (9 Months) | Change |
|---|---|---|---|
| Total Revenues | $10,929 million | $10,796 million | +1.2% |
| Premiums | $9,200 million | $9,058 million | +1.6% |
| Net Investment Income | $1,614 million | $1,554 million | +3.9% |
| Realized Investment Gains | $75 million | $155 million | -51.6% |
| Net Earnings | $1,150 million | $1,119 million | +2.8% |
| Diluted EPS | $2.29 | $2.20 | +4.1% |
| Operating Cash Flow | $3,244 million | $3,464 million | -6.4% |
| Total Assets | $58,353 million | $56,361 million | +3.5% |
| Total Liabilities | $50,326 million | $48,434 million | +3.9% |
| Shareholders' Equity | $8,027 million | $7,927 million | +1.3% |
| Notes Payable | $1,439 million | $1,395 million | +3.2% |
Material Changes and Segment Performance
- Realized Investment Gains: Significant decrease in realized gains ($75M vs $155M prior year) due to the conclusion of a bond-swap program initiated in late 2005 to utilize tax loss carryforwards.
- Aflac Japan:
- Pretax operating earnings increased to $1,264 million (from $1,178 million).
- Premium income decreased slightly in yen terms (-1.4%) but increased in dollar terms (+5.8%) due to exchange rates.
- New annualized premium sales declined 5.8% in yen for the nine months, driven by weak medical sales and a crowded market, though the new "WAYS" ordinary life product performed well.
- Aflac U.S.:
- Pretax operating earnings increased to $459 million (from $396 million).
- Premium income grew 9.6% to $2,642 million.
- New annualized premium sales rose 9.7%, led by accident/disability and hospital indemnity products.
- Foreign Currency: The yen weakened against the dollar (average rate 115.82 in 2006 vs 107.79 in 2005), which suppressed reported dollar results for Aflac Japan compared to prior periods.
Guidance, Outlook, and Risks
- Earnings Guidance: Management's objective for full-year 2006 is net earnings per diluted share of at least $2.92 (a 15.0% increase over 2005), excluding realized investment gains/losses, SFAS 133 impacts, and nonrecurring items. This assumes no foreign currency translation impact.
- 2007 Outlook: Targeting a 15% to 16% increase in net earnings per diluted share.
- Dividends: Quarterly dividend increased to $0.13 per share (Q3 2006) from $0.11 (Q3 2005). The board declared a Q4 2006 dividend of $0.16 and a Q1 2007 dividend of $0.185.
- Share Repurchases: Approximately 40 million shares remain available for purchase under repurchase programs as of September 30, 2006.
- Key Risks:
- Foreign Exchange: Fluctuations in the yen/dollar rate significantly impact reported earnings and balance sheet values.
- Interest Rates: Rising rates have reduced the fair value of the investment portfolio (unrealized gains dropped from $2.5B to $1.1B).
- Regulatory: New mortality tables and reserving rules in Japan effective April 2007 may impact pricing and reserves.
- Market Conditions: Crowded market conditions in Japan and competitive pressures in the U.S.
Investor Verification Checklist
- Investment Portfolio Quality: Verify the status of below-investment-grade securities (totaling $1.18B amortized cost) and the rationale for not recognizing impairment charges.
- Japan Sales Trends: Monitor the recovery of new annualized premium sales in Japan, specifically the performance of the "WAYS" product versus declining medical sales.
- Foreign Exchange Sensitivity: Assess the impact of the yen/dollar exchange rate on future earnings guidance, as the company explicitly excludes currency translation in its targets.
- Regulatory Changes in Japan: Review the impact of the new mortality tables and stress-testing reserving rules effective April 2007 on future profitability.
- Realized Gains Volatility: Note that realized investment gains are volatile and driven by tax planning (bond swaps) rather than core operations; focus on "Pretax Operating Earnings" for core performance.